Schizophrenia and cancer: the adrenochrome balanced morphism.
Med Hypotheses. 2004;62(3):415-9. doi: 10.1016/S0306-9877(03)00319-0.
Med Hypotheses. 2004.
PMID: 14975514
These relationships seem compatible with one or more genetic risk factors for schizophrenia that offer(s) a selective advantage against cancer. There is experimental evidence that appears to support this possibility. Matrix Pharmaceuticals Inc. has received a US pat …
These relationships seem compatible with one or more genetic risk factors for schizophrenia that offer(s) a selective advantage again …